Literature DB >> 6112567

Treatment of a type II diabetic by a totally implantable insulin infusion device.

H Buchwald, J Barbosa, R L Varco, T D Rohde, W M Rupp, R A Schwartz, F J Goldenberg, T G Rublein, P J Blackshear.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6112567     DOI： 10.1016/s0140-6736(81)92402-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Ultrasound-enhanced polymer degradation and release of incorporated substances.

Authors:  J Kost; K Leong; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 2.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 3.  Technology and the diabetic patient.

Authors:  J C Pickup; D Rothwell
Journal:  Med Biol Eng Comput       Date:  1984-09       Impact factor: 2.602

4.  Portable insulin infusion pumps: what is their role in therapy?

Authors:  R P Eaton
Journal:  Drugs       Date:  1982-04       Impact factor: 9.546

Review 5.  Advances in the treatment of diabetes mellitus in the elderly. Development of insulin analogues.

Authors:  B J Hoogwerf; A Mehta; S Reddy
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

6.  Implanted constant basal rate insulin infusion devices for Type 1 (insulin-dependent) diabetic patients.

Authors:  H Kritz; G Hagmüller; R Lovett; K Irsigler
Journal:  Diabetologia       Date:  1983-08       Impact factor: 10.122

Review 7.  Implantable insulin pumps and metabolic control.

Authors:  K D Hepp
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

8.  Long-term intraperitoneal insulin delivery.

Authors:  H A Pitt; C D Saudek; H A Zacur
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.